Haverkamp F, Normann D, Küster W, Zerres K
Universitäts-Kinderklinik Bonn.
Geburtshilfe Frauenheilkd. 1990 May;50(5):339-43. doi: 10.1055/s-2008-1026257.
Familial occurrence in chronic inflammatory bowel disease is well established. Recurrence risks for first degree relatives range from 1 to 5%. A pregnancy is usually not negatively influenced by the disease. The risks for miscarriages are slightly increased, if conception takes place during periods of inflammatory activity. In the case of first manifestation during pregnancy, however, mother and child are exposed to increased risks. The course of the disease is usually not negatively influenced by pregnancy. The rate of relapse is similar to that of comparable samples without pregnancy. In women with an active disease, the prognosis is considerably poorer. The risk to children as a result of drug therapy can be regarded as low. Family planning, pregnancy and birth entail an increased psychological demand, which, in turn, necessitates specific therapy in some cases.
慢性炎症性肠病的家族聚集性已得到充分证实。一级亲属的复发风险为1%至5%。妊娠通常不会受到该疾病的负面影响。如果在炎症活动期受孕,流产风险会略有增加。然而,如果在孕期首次发病,母亲和孩子都面临更高的风险。妊娠通常不会对疾病进程产生负面影响。复发率与未怀孕的对照样本相似。对于病情活跃的女性,预后要差得多。药物治疗对孩子的风险可视为较低。计划生育、妊娠和分娩带来了更多的心理需求,这在某些情况下又需要特殊治疗。